FENOGLIO, DANIELA
 Distribuzione geografica
Continente #
EU - Europa 15.649
Totale 15.649
Nazione #
IT - Italia 15.649
Totale 15.649
Città #
Genova 12.487
Rapallo 1.738
Genoa 1.379
Bordighera 45
Totale 15.649
Nome #
Natural analogue peptides of an HIV-1 GP120 T-helper epitope antagonize response of GP120-specific human CD4 T-cell clones. 232
Non-antigen-specific CD8(+) T suppressor lymphocytes in diseases characterized by chronic immune responses and inflammation. 221
Glutathione-mediated antioxidant response and aerobic metabolism: two crucial factors involved in determining the multi-drug resistance of high-risk neuroblastoma 184
The Ligurian Human Immunodeficiency Virus Clinical Network: A Web Tool to Manage Patients With Human Immunodeficiency Virus in Primary Care and Multicenter Clinical Trials 180
CD8+CD28-CD127loCD39+regulatory T-cell expansion: A new possible pathogenic mechanism for HIV infection? 172
Frequency of telomerase-specific CD8+ T lymphocytes in patients with cancer 149
Immunogenicity of GX301 cancer vaccine: Four (telomerase peptides) are better than one 146
A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer 145
Antagonistic activity of HIV-1 T helper peptides flanked by an unrelated carrier protein. 141
White matter microstructure alterations correlate with terminally differentiated CD8+ effector T cell depletion in the peripheral blood in mania: Combined DTI and immunological investigation in the different phases of bipolar disorder 141
Advancements on phenotypic and functional characterization of non-antigen-specific CD8+CD28- regulatory T cells 140
B cells on the podium: regulatory roles of surface and secreted immunoglobulins. 140
A Standard Interface for Data Reuse in Infectious Diseases 140
Comparative analysis of cancer vaccine settings for the selection of an effective protocol in mice 138
Attenuated Listeria monocytogenes carrier strains can deliver an HIV-1 gp120 T helper epitope to MHC class II-restricted human CD4+ T cells. 137
Human T leukaemia virus type 1 (HTLV-1) specific T-helper cell response: clonal fluctuations and repertoire heterogeneity. 135
Anti-HIV genetic treatment of antigen-specific human CD4 lymphocytes for adoptive immunotherapy of opportunistic infections in AIDS. 134
Th17 and regulatory T lymphocytes in primary biliary cirrhosis and systemic sclerosis as models of autoimmune fibrotic diseases. 134
Human T helper cells specific for HIV reverse transcriptase: possible role in intrastructural help for HIV envelope-specific antibodies. 130
CD8+CD28− T Suppressor Lymphocytes Inhibiting T Cell Proliferative and Cytotoxic Functions Infiltrate Human Cancers 129
Effect of antigen/antibody ratio on macrophage uptake, processing, and presentation to T cells of antigen complexed with polyclonal antibodies. 128
Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis. 127
Multicentre Clinical Trials’ data management: A hybrid solution to exploit the strengths of Electronic Data Capture and Electronic Health Records systems 126
Abscisic acid ameliorates the systemic sclerosis fibroblast phenotype in vitro. 126
Early and repeated IgG1Fc-pCons chimera vaccinations (GX101) improve the outcome in SLE-prone mice 126
Increased CD38 expression on T lymphocytes as a marker of HIV dissemination into the central nervous system 126
HO-1 up-regulation: A key point in high-risk neuroblastoma resistance to bortezomib. 126
Generation of more effective cancer vaccines. 125
Sublingual immunotherapy-induced IL-10 production is associated with changed response to the decongestion test: preliminary results. 124
A restricted T cell response to myelin basic protein (MBP) is stable in multiple sclerosis (MS) patients. 124
Residual tumor micro-foci and overwhelming regulatory T lymphocyte infiltration are the causes of bladder cancer recurrence 124
Recombinant IL-21 and anti-CD4 antibodies cooperate in syngeneic neuroblastoma immunotherapy and mediate long-lasting immunity 123
Feasibility and Efficacy of Post-Transplant Consolidation Immunotherapy with Nivolumab Supported By the Reinfusion of Unselected Autologous Lymphocytes in Patients Affected By Relapsed/Refractory Hodgkin Lymphoma 123
Sublingual immunotherapy induces spirometric improvement associated with IL-10 production: preliminary reports. 122
Antigen-presenting function of human peritoneum mesothelial cells 122
Role of Nrf2, HO-1 and GSH in neuroblastoma cell resistance to bortezomib 122
Analysis of the antigen specific T cell repertoires in HIV infection 121
Relevance of CD38 expression on CD8 T cells to evaluate antiretroviral therapy response in HIV-1-infected youths 121
Antigenicity of HIV-derived T helper determinants in the context of carrier recombinant proteins: effect on T helper cell repertoire selection. 120
Relationship between innate immunity, soluble markers and metabolic-clinical parameters in HIV+ patients ART treated with HIV-RNA < 50 cp/mL 119
Indoleamine 2,3 dioxygenase gene polymorphisms correlate with CD8+ Treg impairment in systemic sclerosis. 116
Enhanced activation of human T cell clones specific for virus-like particles expressing the HIV V3 loop in the presence of HIV V3 loop-specific polyclonal antibodies 114
Resistance of neuroblastoma GI-ME-N cell line to glutathione depletion involves Nrf2 and heme oxygenase-1. 113
Intravenous immunoglobulin, plasmalymphocytapheresis and azathioprine in chronic progressive multiple sclerosis. 111
CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes 111
Effect of cyclosporine on the antigen-presenting function of human and murine accessory cells. 111
Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosuppression 111
AIRE polymorphism, melanoma antigen-specific T cell immunity, and susceptibility to melanoma 111
Vdelta1 T lymphocytes producing IFN-gamma and IL-17 are expanded in HIV-1-infected patients and respond to Candida albicans 110
Serum leptin levels in patients with pollen-induced allergic rhinitis. 110
Serum interleukin-17 levels are related to clinical severity in allergic rhinitis 110
Quantitative analysis of peripheral allergen-specific B lymphocytes in asthma. 109
Human T-helper cell recognition of an immunodominant epitope of HIV-1 gp120 expressed on the surface of Streptococcus gordonii. 109
Genetically modified immunocompetent cells in HIV infection. 108
Handling of retroviral antigens by human antigen-presenting cells 107
Impaired immune response to Candida albicans in cells from Fanconi anemia patients 107
Serum IL-17 levels in patients with allergic rhinitis 106
A new marine-derived sulfoglycolipid triggers dendritic cell activation and immune adjuvant response 106
Th17 cells and allergic rhinitis: Is there clinical relevance? 105
Role of flanking variable sequences in antigenicity of consensus regions of HIV gp120 for recognition by specific human T helper clones 105
Rete Ligure dell’HIV: due anni di esperienza nella gestione del dato clinico 105
Conserved T cell and natural killer cell function in treatment-experienced adults receiving tenofovir plus didanosine reverse transcription inhibitor backbone 104
CD8(+) T regulatory/suppressor cells and their relationships with autoreactivity and autoimmunity 104
Novel Immunoenzymatic assay for identification of coagulase- and protein A- negative Staphylococcus aureus strains. 103
Cd4(+) T cell response to Leishmania spp. in non-infected individuals 102
Cyclophosphamide inhibits the generation and function of CD8(+) regulatory T cells. 102
Endocrine regulation of suppressor lymphocytes: role of the glucocorticoid-induced TNF-like receptor 102
Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adults. 102
Use of maraviroc in clinical practice: a multicenter observational study 101
Recognition of antigenic clusters of Candida albicans by T lymphocytes from human immunodeficiency virus-infected persons 101
null 99
Circulating lymphocyte subsets after total lymphoid irradiation in chronicprogressive multiple sclerosis. 99
Non-antigen specific CD8+ T suppressor lymphocytes. 99
Cytokine gene expression and T-cell proliferative responses in lymph node mononuclear cells from children with early stage human immunodeficiency virus infection. 98
Serum IL-17 after one course of sublingual immunotherapy in allergic rhinitis to birch 98
Peripheral TH-17 cells in children with allergic rhinitis: preliminary report. 98
The plant hormone abscisic acid increases in human plasma after hyperglycemia and stimulates glucose consumption by adipocytes and myoblasts 97
Requirement for different presenting cells and for different processing mechanisms by human CD4 T helper clones specific for M. tuberculosis antigens. 97
Detection of T cell CD4 epitopes in HIV-infected individuals 96
The serum capacity to solubilize immune complexes (ICSC) measured by an enzyme-anti-enzyme complex probe 96
Analisi e studio longitudinale della fine specificità di linee linfocitarie T specifiche per la proteina basica della mielina (MBP) in pazienti con sclerosi multipla e in controlli normali. 96
Adipokines and sublingual immunotherapy: preliminary report. 95
Rational reconstitution of the immune repertoire in AIDS with autologous, antigen-specific, in vitro-expanded CD4 lymphocytes 95
Fingolimod Modulates Peripheral Effector and Regulatory T Cells in MS Patients. 93
Nanoparticles increase the efficacy of cancer chemopreventive agents in cells exposed to cigarette smoke condensate 93
null 92
Dysregulation in B-cell responses and T follicular helper cell function in ADA2 deficiency patients 92
Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis. 91
Sublingual immunotherapy provides an early increase of interferon-gamma production. 91
Glutathione and the switch of aerobic metabolism collaborate for multi-drug resistance of neuroblastoma 91
Adhesion molecules and kinases involved in gammadelta T cells migratory pathways: implications for viral and autoimmune diseases. 90
Flu vaccination with a virosomal vaccine does not affect clinical course and immunological parameters in scleroderma patients 89
Peripheral Th-17 cells in allergic rhinitis: New evidence 89
Prevention of Lymphocyte Neurotoxic Effects by microRNA Delivery. 89
The role of AIRE polymorphisms in melanoma. 88
Assessment of humoral and cell-mediated immunity against Bordetella pertussis in adolescent, adult, and senior subjects in Italy 88
Rationale for an association between PD1 checkpoint inhibition and therapeutic vaccination against HIV 88
null 87
Single nucleotide polymorphisms in the promoter regions of Foxp3 and ICOSLG genes are associated with Alopecia Areata. 87
HIV-1 resistant, antigen specific CD4 lymphocytes for adoptive therapy of acquired immune deficiency. 86
Totale 11.546
Categoria #
all - tutte 41.233
article - articoli 36.632
book - libri 0
conference - conferenze 4.298
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 303
Totale 82.466


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019742 0 0 0 0 0 0 0 0 0 0 402 340
2019/20204.499 179 98 200 295 411 517 757 289 385 710 508 150
2020/20211.403 101 177 180 111 56 133 68 116 99 139 115 108
2021/20222.076 52 111 203 206 130 124 103 500 100 193 90 264
2022/20232.119 198 166 22 221 317 396 12 166 308 26 251 36
2023/20241.077 58 132 32 143 111 239 103 77 54 69 59 0
Totale 15.904